Pfizer Inc.(PFE)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
PFE | 164.21 B | 37.42x | 2.60% | 6.80% | $0.77 | 5.01% | 0.74 | 6.15% | $28.70 | $22.03 |
LLY | 1.03 T | 38.86x | 47.70% | 33.53% | $29.84 | 1.02% | 1.62 | 59.00% | $1292.65 | $707.59 |
JNJ | 670.99 B | 32.26x | 6.60% | 21.48% | $8.63 | 25.74% | 0.58 | 2.00% | $275.11 | $169.51 |
ABBV | 459.82 B | 73.30x | 10.20% | 9.80% | $3.55 | - | - | 2.71% | $267.47 | $189.40 |
AZN | 255.54 B | 24.63x | 6.40% | 17.02% | $6.69 | 21.97% | 0.64 | 1.96% | $210.52 | $144.30 |
NVO | 158.93 B | 11.62x | 2.10% | 35.35% | $4.09 | 59.82% | 0.63 | 3.96% | $61.11 | $34.15 |
Peer Valuation & Performance Analysis
Peer group analysis for Pfizer Inc. (PFE) compared to its primary competitors (including LLY, JNJ, ABBV) reveals distinct metrics. PFE trades roughly in line with its competitors, with a P/E ratio of 37.4x versus the peer average of 36.7x, reflecting valuation parity within the industry. In terms of growth, PFE's revenue growth of 2.6% lags behind the peer average of 12.7%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of 6.8% is below the peer average of 20.9%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• PFE ranks #3 in P/E ratio, #5 in revenue growth, and #5 in profit margins
• Average ranking: #4 - ⚠️ Room for improvement relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $29.09 | $29.21 | $28.44 | $28.81 | 26,693,700 | -0.96% |
| 2026-09-02 | $28.79 | $29.09 | $28.71 | $29.02 | 39,277,900 | +0.80% |
| 2026-09-01 | $28.82 | $29.09 | $28.47 | $28.55 | 42,493,400 | -0.94% |
| 2026-08-31 | $27.85 | $28.70 | $27.64 | $28.46 | 45,930,300 | +2.19% |
| 2026-08-28 | $28.00 | $28.02 | $27.77 | $27.96 | 27,175,800 | -0.14% |
| 2026-08-27 | $27.97 | $28.18 | $27.83 | $28.02 | 31,174,400 | +0.18% |
| 2026-08-26 | $28.44 | $28.50 | $28.15 | $28.30 | 35,070,000 | -0.49% |
| 2026-08-25 | $27.92 | $28.58 | $27.84 | $28.57 | 31,915,700 | +2.33% |
| 2026-08-24 | $28.10 | $28.16 | $27.81 | $27.97 | 23,845,600 | -0.46% |
| 2026-08-21 | $27.77 | $28.43 | $27.66 | $28.07 | 37,109,600 | +1.08% |
| 2026-08-20 | $28.00 | $28.16 | $27.65 | $27.79 | 29,247,500 | -0.75% |
| 2026-08-19 | $27.60 | $28.44 | $27.58 | $28.24 | 59,675,200 | +2.32% |
| 2026-08-18 | $27.15 | $27.40 | $27.10 | $27.25 | 34,641,000 | +0.37% |
| 2026-08-17 | $26.76 | $27.02 | $26.55 | $26.87 | 29,261,200 | +0.41% |
| 2026-08-14 | $26.66 | $26.92 | $26.42 | $26.79 | 23,167,800 | +0.49% |
Explore More Analysis for PFE
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.